Clinical Trial Update: MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment [Phase 2, Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2/Phase 3 trial evaluating mesenchymal stem cells with or without peripheral blood stem cells for treating poor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Platelet Engraftment
• Hematologic Diseases
• Poor Graft Function

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)
• Peripheral blood stem cells (peripheral blood stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Stem Cell Transplantation, Hematopoietic, Poor Graft Function | Phase 2, Phase 3 | Status: UNKNOWN